All Stories

  1. Estimation on conditional restricted mean survival time with counting process

    Article • Journal of Biopharmaceutical Statistics, August 2019, Taylor & Francis

    Dr H.M. James Hung

  2. Commentary on “Applying CHW method to 2-in-1 design: gain or lose”

    Article • Journal of Biopharmaceutical Statistics, June 2019, Taylor & Francis

    Dr H.M. James Hung

  3. Regulatory experience of qualifying total kidney volume as a prognostic biomarker for clinical trial enrichment*

    Article • Statistics in Biopharmaceutical Research, March 2019, Taylor & Francis

    Dr H.M. James Hung

  4. Difference in Restricted Mean Survival Time: Small Sample Distribution and Asymptotic Relative Efficiency

    Article • Statistics in Biopharmaceutical Research, January 2019, Taylor & Francis

    Dr H.M. James Hung

  5. Comments on ‘Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls’

    Article • Statistics in Medicine, January 2016, Wiley

    Dr H.M. James Hung

  6. Some Challenges With Statistical Inference in Adaptive Designs

    Article • Journal of Biopharmaceutical Statistics, August 2014, Taylor & Francis

    Dr H.M. James Hung